July 2018 Letter to Shareholders

July 25, 2018

Dear valued shareholders,  

It has been an incredibly long journey for EastWest Science over the last year and I sincerely appreciate all your support. Thank you for your loyalty and patience as our company continues to expand and grow.

Today, we embark on an exciting new chapter with the official listing of our company on the TSX Venture Exchange (TSX-V). We will be trading under the symbol “EAST-TSXV” following the approved merger of EastWest Science with Harbour Star Capital to become EastWest BioScience Group. Click the link  to read the press release published on Monday.

Due to the merger and name change that has happened, new certificates or depository receipt securities (DRS) must be issued. Certificates will be issued and traded in the name of Harbour Star Capital for the first 30-60 days until we receive shareholder approval regarding the Harbour Star name change at a Harbour Star AGM in Alberta. Our new transfer agent will be sending out these new DRS certificates to all shareholders immediately.

NOTE: Do not send your 1011705 Certificates to the transfer agent as they will be rejected. New DRS certificates will replace the old certificates and the new ones are being sent to you.  Any questions or issues regarding this matter, please contact us at certificates@eastwestscience.com.

This public listing announcement is a big step for our company and we could not have done it without your patience and support. It has inspired us even more to continue to strive for excellence in all products and services that our company has to offer.

We expect significant developments to take place in the near future, so we will be significantly improving our communications with you through routine email updates. In addition, our investors relations department is always open to hear any feedback from our shareholders. Please send inquiries to investors@eastwestscience.com at any time.

Sincerely,

Rodney Gelineau
President and CEO